We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Simulations Plus Inc | NASDAQ:SLP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.51 | 3.23% | 48.21 | 42.90 | 49.99 | 48.31 | 46.79 | 47.17 | 89,381 | 23:31:41 |
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, announced today that Walt Woltosz, chairman and chief executive officer, will present at the Needham Emerging Technology Conference on Wednesday, May 17, 2017, at 12:50 p.m. EDT. The conference will be held at the Westin Grand Central Hotel in New York City.
For more information on Needham’s Emerging Technology Conference, please visit http://www.needhamco.com/.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at www.simulations-plus.com.
Follow us on Twitter | LinkedIn
View source version on businesswire.com: http://www.businesswire.com/news/home/20170511005425/en/
Simulations Plus Investor RelationsMs. Renee Bouche, 661-723-7723renee@simulations-plus.comorHayden IRMr. Cameron Donahue, 651-653-1854cameron@haydenir.com
1 Year Simulations Plus Chart |
1 Month Simulations Plus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions